Takayasu and Giant Cell Arteritis Unmasked by Vedolizumab as Paradoxical Reactions: Two Case Reports

Ähnliche Einträge

• Outcomes of an Intravenous to Subcutaneous Infliximab ( CT ‐ P13 ) Strategy in Takayasu Arteritis: A Proof‐of‐Concept Prospective Study
  von: Luca Iorio, et al.
  Veröffentlicht: (2026)
• Giant Cell Arteritis Refractory to Interleukin‐6 and Interleukin‐17 Inhibition Treated With Upadacitinib
  von: Luke S. Vest, et al.
  Veröffentlicht: (2025)
• Quantification of Vascular Burden on Cranial Vessel Wall Magnetic Resonance Imaging and Ophthalmic Complications in Giant Cell Arteritis
  von: David L. Yang, et al.
  Veröffentlicht: (2026)
• Combined Orbital and Cranial Vessel Wall Magnetic Resonance Imaging for the Assessment of Disease Activity in Giant Cell Arteritis
  von: Rennie L. Rhee, et al.
  Veröffentlicht: (2024)
• Use of 18F‐fluorodeoxyglucose Positron Emission Tomography to Monitor Disease Activity in Patients With Giant Cell Arteritis on Tocilizumab
  von: Kaitlin A. Quinn, et al.
  Veröffentlicht: (2025)